The burden and risk factors for adverse drug events in older patients - A prospective cross-sectional study

South African Medical Journal

Volumn 96, Issue 12 I, 2006, Pages 1255-1259

  Tipping, Brent ^a   Kalula, Sebastiana ^a   Badri, Motasim ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; VITAMIN; WARFARIN;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; EMERGENCY WARD; FEMALE; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MALE; MEDICAL AUDIT; PATIENT COMPLIANCE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG THERAPY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA;

EID: 33846116966     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schneeweiss S, Hanford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285-291.
2. Pirohamed M, James S. Meakin S, et al. Adverse drug reactions as cause of admission to hospital: perspective analysis of 18820 patients. BMJ 2004; 329: 15-19.
3. Nebeker JR, Leach P, Samore MH. Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801.
4. Committee on Quality of Health Care in America, Institute of Medicine. To Err is Human - Building a Safer Health System. Washington, DC: National Academy Press, 1999.
5. Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Ageing 1999; 14: 231-239.
6. Kelly J, Kelleher K. Review: β-blocker use in elderly patients with coronary heart disease. Age Ageing 2000; 29: 17-21.
7. Morton JA, Newton J, Gray CS. Counting the true cost of antiplatelet therapy for stroke prevention. Age Ageing 2005; 34: 212-214.
8. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871-878.
9. Mannesse CK, Derkx FHM, De Ridder MAJ, Man in't Veld AJ, Van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-39.
10. Burgess CL, D'Arcy CD, Holman J, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005; 12: 267-270.
11. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals: methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375-382.
12. Sinha U, Raha S, Wilkins E. Adverse drug reactions and hospital admission of older patients. Age Ageing 2000; 29: 551-552.
13. Hallas J. Drug related hospital admissions in subspecialities of internal medicine. Dan Med Bull 1996; 43: 141-155.
14. Malhotra S, Karan RS, Pandhi P, Jain S. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703-707.
15. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666-671.
16. Howard R, Avery T. Inappropriate prescribing in older people. Age Ageing 2004; 33: 530-532.
17. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116.
18. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharm Res 2004; 30: 631-636.
19. Patrono C, Garcia Rodriquez LA, Landolfi R, Baigent C. Drug therapy: Low-dose aspirin for prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-2383.
20. Garcia DA, Hylek EM. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med 2006; 22: 155-166.
21. Nathan D. Clinical practice: initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002; 347: 1342-1349.
22. Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994: 23: 255-259.